Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus

AIM: The objective of this study was to assess if avibactam, a new β-lactamase inhibitor, can restore the potency of carbapenems, a sub-class of β-lactams, against Mycobacterium abscessus clinical isolates. MATERIALS & METHODS: 28 M. abscessus clinical isolates that are resistant to multiple dru...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Future Microbiol
Päätekijät: Kaushik, Amit, Gupta, Chhavi, Fisher, Stefanie, Story-Roller, Elizabeth, Galanis, Christos, Parrish, Nicole, Lamichhane, Gyanu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Future Medicine Ltd 2017
Aiheet:
Short Communication
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5618940/
https://ncbi.nlm.nih.gov/pubmed/28326811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fmb-2016-0234
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia